Among the most successful fund investment fields, there are Health Care, Manufacturing. The fund has specific favorite in a number of founders of portfolio startups. Among the various public portfolio startups of the fund, we may underline Rapid Micro Biosystems, Mimetogen Pharmaceuticals, AngioChem Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The high activity for fund was in 2005. Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the VIMAC Milestone Medical Fund, startups are often financed by iNovia Capital, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are TVM Capital, Quaker BioVentures, MSBi Valorisation. In the next rounds fund is usually obtained by Medwell Capital, TVM Capital, TPG Biotech.
Related Funds
| Fund Name | Location |
| ARIA Fund | Mazowieckie, Poland, Warszawa |
| CVSHealth | Rhode Island, United States, Woonsocket |
| CX Venture Group | - |
| Deloitte Tohmatsu Capital | Japan, Tokyo |
| EuroFinLeading Private Equity | - |
| Formative Ventures | California, Santa Clara, United States |
| Global PayTech Ventures | Florida, Miami, United States |
| Huanxin Touzi | China, Guangdong Province, Yuexiu District |
| innogy New Ventures LLC | California, Palo Alto, United States |
| LEGO Brand Group | - |
| LivaNova | England, London, United Kingdom |
| Remy International | Indiana, Pendleton, United States |
| Telluric Foods | - |
| Terra Rossa Capital | Adelaide, Australia, South Australia |
| The Luxury Fund | - |
| Zhongjiancai Touzi | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Rapid Micro Biosystems | $18M | 06 Aug 2009 | Massachusetts, United States | ||
Mimetogen Pharmaceuticals | 23 Mar 2006 | Montreal, Quebec, Canada | |||
Neotropix | $10M | 02 Feb 2005 | Malvern, Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Rapid Micro Biosystems | $18M | 06 Aug 2009 | Massachusetts, United States | ||
Mimetogen Pharmaceuticals | 23 Mar 2006 | Montreal, Quebec, Canada | |||
Neotropix | $10M | 02 Feb 2005 | Malvern, Pennsylvania, United States |
